NEW YORK, June 10 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
The Australian opioid market grew from $63m in 2005 to $137m in 2009. Its growth will slow considerably and the market will be worth $182m in 2019. As many new drugs to come on the market will be reformulations, Datamonitor assumes that these will be priced at a similar level as currently available brands in order to receive reimbursement. This means that the value of the market will stabilize.
Reasons to Purchase
*Identify key opportunities and threats that will impact the Australian opioid market as a whole and key brands and pipeline products in particular.
*Quantify the future size and Scope of the Australian opioid market and predict the performance of its key compounds.
*Understand critical success factors in growing and defending opioid brand franchises from new entrants and generics.
To order this report:
Intl: +1 805-652-2626